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Introduction: Centralisation of oesophagogastric (OG) resectional services has been proposed to improve
patient outcomes in terms of perioperative mortality and long-term survival. Centralisation of services
occurred in Gloucester 5 years ago. The aim of this paper is to assess if local patient outcomes have
beneﬁted from centralisation.
Methods: All oesophagogastric resections performed in our unit over a 15-year period (10-years pre-
centralisation and 5-years post-centralisation) were assessed retrospectively. Patient demographics,
pathological details and date of death were identiﬁed. Perioperative mortality (30 and 90 day) and
estimated KaplaneMeier survival was compared for cases performed pre- and post-centralisation of
services.
Results: 456 resections for cancer were performed in the 15-year period; 234 of these were performed
pre-centralisation (mean 23.4, range 13e31) and 222 were performed post-centralisation (mean 44.4,
range 40e50). Median survival rates for gastric cancer were 1.1 years pre-centralisation and 1.5 years
post-centralisation (p ¼ 0.147) and median survival for oesophageal cancer improved from 1.1 years to 2.1
respectively (p ¼ 0.028). Combined OG 30-day mortality rates improved from 10.3% pre-centralisation to
3.6% post-centralisation (p ¼ 0.006, Fisher’s exact test).
Discussion: Centralisation of OG services in Gloucester has resulted in twice as many resections being
performed locally. Median survival for patients with oesophageal cancer has increased by 1 year and the
30-day mortality rate following resection has reduced by almost two thirds. Although other factors (such
as improvements in oncological treatments, staging and critical care management over the 15-year time
period) have undoubtedly had roles to play in these improvements, the results of this study support the
policy of centralisation of Upper GI cancer services.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Oesophagogastric (OG) carcinoma has traditionally been asso-
ciated with poor outcomes, both in terms of operative mortality
and long-term outcome.1 Although these outcomes are greatly
inﬂuenced by late presentation and an elderly population (often
with multiple co-morbidities), the experience of the operating
surgeon and the multidisciplinary team may impact on patient
survival.1e3inal Surgeons of Great Britain
rgery, Level 3 Dolphin House,
l BS2 8HW, UK. Tel.: þ44 (0)
343 4751.
ddy).
4.
ciates Ltd. Published by Elsevier LtIn 2001, the Clinical Outcomes Group in the UK recommended
the centralisation of OG cancer services into centres with
a minimum population of 1 million.4 In a centre of this size it was
expected that 250 cases would be discussed at the OG Multidisci-
plinary Team meeting (MDT) and 100 resections would be per-
formed annually. The expected increase in surgical experience was
thought to improve post-operative outcomes. More recently, in
their guidance published in 2010, the Association of Upper
Gastrointestinal Surgeons of Great Britain and Ireland calculated
that for a population of a million people there would be 52 major
OG resections per year.5 They suggested that an ideal OG unit
would consist of four to six surgeons, each performing a minimum
of 15e20 resections per year, serving a population of one to two
million people.
Where a single institution does not have a sufﬁcient catchment
area to support an OG unit, centralisation of services can provide
the population and workload to ensure that the minimum number
of resections can be achieved. In our region, prior to centralisation,d. All rights reserved.
Table 1
Demographics of patients pre- and post-centralisation.
Prior to 2006 Since 2006 p value
Gastric 126 106
Oesophageal 108 116
Total 234 222
Annual mean (range) 23.4 (13e31) 44.4 (40e50) <0.001a
% Male 74.8% 83.8% 0.018b
Gastric 72.2% 79.2% n.s.b
Oesophageal 77.7% 87.9% 0.043b
Median age (Range) 68.0 (34.2e90.2) 66.5 (19.4e86.2) n.s.c
Gastric 72.9 (34.2e90.2) 72.8 (19.4e86.2) n.s.c
Oesophageal 63.6 (36.7e81.3) 62.9 (26.4e81.6) n.s.c
a t-test.
b Chi squared.
c Mann Whitney.
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Worcester and Hereford by independent surgeons. In 2006 the
establishment of the Three Counties Cancer Network for OG cancer
centralised services at the Gloucestershire Royal Hospital (GRH);
the catchment area includes Gloucestershire, Herefordshire and
South Worcestershire, a population of just over a million. All OG
cases are discussed at a central MDTmeeting, which is co-ordinated
at Gloucester. We currently have three OG surgeons based locally
and have a further two surgeons from Worcester and Cheltenham
who perform all perform their resectional work at GRH.
2. Aim
To assess the beneﬁt of centralisation of services, a retrospective
15-year audit was performed looking at patient outcomes pre- and
post-centralisation of OG resectional surgery in 2006. 30-day and
90-day mortality and estimated median survival were deﬁned as
targets for audit.
3. Methods
All OG resections for carcinoma performed in our unit from 1st January 1996
until 31st December 2010 were identiﬁed from a combination of previous depart-
mental audit data, hospital coding data, MDT outcome data and operating diaries.
This data included 10-year pre-centralisation of service and 5-years post-
centralisation. Patients and demographic details were entered onto a database
along with operation date. Histological details were added to the database along
with date of death obtained from the hospital patient administration system (PAS).
Cancer sites were classiﬁed as oesophageal or gastric according to the dataset that
was used for recording the pathological ﬁndings. The tumour (T) status, node (N)
status and stage of each tumour were classiﬁed according to the sixth edition of the
TNM classiﬁcation for oesophageal and gastric cancers (sub stages a or b were not
used).6 30- and 90-day mortality pre and post centralisation were compared using
Fischer’s exact test. Cancer site and stage speciﬁc KaplaneMeier survival curves
were constructed for cases pre and post centralisation and were compared using the
Generalised Wilcoxon test. Factors effecting survival were also examined using Cox
regression analysis (forward stepwise conditional entry of factors). Factors entered
into the model were time period, surgeon, TNM stage, patient age and cancer site.
Statistical analysis was performed with IBM SPSS 19 (IBM, Armonk, New York, USA).
p < 0.050 was considered statistically signiﬁcant.
Patients who did not have a date of death on the hospital systems but had no
local postoperative follow-upwere considered lost to follow up. These patients were
not included in the long term survival analysis but were included in the 30- and 90-
day mortality analysis.Fig. 1. Operations performed by year.4. Results
In total 456 resections were performed in Gloucester over the 15
year period (Fig. 1). 234 of these resections were performed pre-
centralisation, giving an average of 23.4 per year (range 13e31).
222 resections were performed post-centralisation, giving an
average of 44.4 per year (range 40e50). This increase in number
of resections being performed at Gloucester was statistically
signiﬁcant (p < 0.001, t-test).
In terms of the type of resectional work being performed 126
resections (53.8%) were for gastric cancer and 108 (46.2%) were for
oesophageal cancer pre-centralisation. Post-centralisation 106
resections (47.7%) were for gastric cancer whilst 116 (52.3%) were
for oesophageal cancer. Patient demographics are shown in Table 1.
There were no signiﬁcant differences in the ages of patients pre- or
post-centralisation. Although there was no signiﬁcant change in
the proportion of male patients who had gastric resections (72.2%
pre 2006 v 79.2% post 2006, p ¼ 0.216 Chi squared), there was
a higher proportion of male patients who had oesophageal resec-
tions after centralisation (77.8% pre 2006 v 87.9% post 2006,
p ¼ 0.043 Chi squared).
5. Cancer staging
Analysis of the pathological stages of tumours pre- and post-
centralisation did not reveal any signiﬁcant change for gastric
carcinoma. However, there was an increase in the proportion of
stage 1 oesophageal cancers after centralisation (6%e16%, p< 0.05).
The number of resections for other stages of oesophageal was
similar pre- and post-centralisation (Table 2).
6. Mortality
Overall the 30-day mortality fell from 10.3% pre-centralisation
to 3.6% post-centralisation (p ¼ 0.006) (Table 3). The reductionsTable 2
Tumour stage of gastric and oesophageal resections pre- and post-centralisation.
Gastric Oesophageal
Stage Pre 2006 Post 2006 p valuea Pre 2006 Post 2006 p valuea
0 1 n.s 3 n.s
1 25 21 n.s 6 19 <0.05
2 17 19 n.s 45 37 n.s
3 62 41 n.s 55 51 n.s
4 22 24 n.s 2 6 n.s
Total 126 106 108 116
a Comparison of column proportions (z-test) with Bonferoni correction for
multiple comparisons.
Table 3
30 and 90 day mortalities for gastric and oesophageal resections.
Prior to 2006 Since 2006 p valuea
30 day mortality 10.3% 3.6% P ¼ 0.006
Gastric 9.5% 2.8% P ¼ 0.058
Oesophageal 11.1% 4.3% P ¼ 0.076
90 day mortality 15.0% 9.0% P ¼ 0.061
Gastric 15.9% 7.5% P ¼ 0.068
Oesophageal 13.8% 10.3% P ¼ 0.539
a Fischer’s exact test.
Table 4
Results of Cox regression analysis showing odds ratios and 95% conﬁdence interval
of signiﬁcant factors.
p value OR 95% CI
Stage 1 <0.001
Stage 2 0.028 1.621 1.053 2.494
Stage 3 <0.001 3.031 2.044 4.495
Stage 4 <0.001 5.974 3.693 9.665
Cancer centre 0.026 0.760 0.597 0.968
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but analysis of this data did not reach signiﬁcance due to the
relatively small numbers of operations in each group. We noted
a reduction in 90-day mortality from 15% pre-centralisation to 9%
post-centralisation for all resections, but this was not statistically
signiﬁcant. Mortality from 30 to 90 days was similar before cen-
tralisation (4.3%) and after centralisation (5.8%). However, whereas
all ten of the patients who died in this period before centralisation
had stage 3 or 4 disease, six of the thirteen patients who died in this
period after centralisation had stage 1 or 2 disease and died of
complications of surgery (anastomotic leaks, chest sepsis or
pulmonary embolism), generally after prolonged stays in the
intensive care unit.7. Survival
We noticed an improvement in patient survival for both gastric
and oesophageal cancer resections (Fig. 2). Median survival
following gastric resection increased from 1.1 years to 1.6 years
post-centralisation for all cancer stages. This was not statistically
signiﬁcant (p ¼ 0.147, Generalised Wilcoxon test). Median survival
following oesophageal resection increased from 1.1 to 2.1 years
post-centralisation for all cancer stages. This improvement in
survival was statistically signiﬁcant (p ¼ 0.028).
There could be many reasons for this improved survival in the
last 5 years compared to the previous 10 years. However when
survival results (for gastric and oesophageal resections combined)
were examined in three time periods (1996e2000, 2001e2005,p=0.147
Fig. 2. KaplaneMeier estimated survival cur2006e2010) rather than two, there was no difference in median
survival between 1996 and 2000 (estimated median survival 1.29
years) and 2001e2005 (1.21 years, p ¼ 0.668 Generalised Wilcoxon
test) whereas median survival from 2006 to 2010 was signiﬁcantly
longer (1.92 years, p ¼ 0.042 verses 1996e2000 and p ¼ 0.013
verses 2001e2005). This suggests that rather than a gradual
improvement in results over the entire time period 1996e2010 (as
may be expected if the improved outcomes were purely related to
general improvements in areas such as critical care and neo-
adjuvant/adjuvant oncological therapy), there was a stepwise
improvement occurring around 2006, coinciding with the cen-
tralisation of Upper GI cancer services in our unit.8. Cox regression analysis
In order to establish which factors had improved our survival
outcomes a Cox regression analysis was performed. The variables
that were assessed were: cancer stage, patient age, surgeon, cancer
centre (pre/post centralisation) and whether the cancer was gastric
or oesophageal. Of these variables, only TNM stage and the effect of
centralisation were found to be signiﬁcant independent factors
(Table 4).9. Discussion
There are many reasons why oesophagogastric surgery is asso-
ciated with poor survival outcomes, including late presentation,
patient age and co-morbidities. However, over the past decade,
many studies have conﬁrmed that OG resection surgery hasp=0.028
ves for gastric and oesophageal cancer.
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mortality, when performed in institutions that have a high turnover
of cases.7e13 What is less clear is whether this beneﬁt is due to the
experience of an individual surgeon, or the collective experience of
the unit.14,15 Specialisation of a surgeon should increase their
experience and technical abilities, but the impact of other health-
care professionals needs to be considered; both other medical staff
who specialise in OG cancer (radiologists, pathologists and oncol-
ogists) and nursing, theatre and ITU staff whose experience greatly
impacts on patient care.3 Long term survival has been shown to
beneﬁt greatly with increasing hospital volume in surgery for
pancreatic cancer,16 but for OG cancer the relationship between
hospital volume and long term survival is less clear.11 In addition to
patient load, case mix clearly impacts on survival outcomes.17
Centralisation has enabled smaller resectional units to combine
to ensure that they reach the current AUGIS guidelines regarding
the size of population served and number of operations per-
formed.5 Our results have shown the impact that centralisation has
had on the OG resectional service at Gloucester. We are now per-
forming almost twice as many operations locally post-
centralisation. We have shown that patients have lower 30-day
mortality and improved long-term survival following centralisation
of services ﬁve years ago. Surgical expertise is likely to play an
important role in this improvement of outcomes, but other factors
should be considered. The collective experience of the unit
(including theatre staff, nursing staff, radiology, intensive care staff,
physiotherapists and dieticians) is also vital to improve patient
outcome. Moreover, better patient selection, via a uniﬁedMDTwith
appropriate preoperative staging in the form of endoscopic ultra-
sound and PET, is likely to play a signiﬁcant role in our improve-
ments in outcome; improved patient selection, via the MDT, is
likely to be the reason why the proportion of stage 1 oesophageal
cancers has increased post-centralisation.
This data therefore supports the policy of centralisation to
achieve the current AUGIS guidelines. Our results are consistent
with previous literature showing improvements in perioperative
mortality in high volume centres, and also provide evidence of
improvements in long term survival.
The main limitation of this study is that although we have
shown an association between improved outcomes at our unit and
the centralisation of services, we have not proved that this
improvement is directly related to centralisation. In addition, we
have only looked at two outcome measures: postoperative
mortality and overall survival. In this study we have not examined
the impact of centralisation on other important outcomes such as
postoperative morbidity and complications, hospital stay, cost or
quality of life. Another limitation is that in our pre centralisation
cohort we have only considered the patients treated at our unit, and
not at the other units performing surgery for OG cancer.10. Conclusion
Our experience with centralisation has shown that smaller units
can survive and ﬂourish within the current AUGIS recommenda-
tion. The improvements in morbidity and mortality support the
guidelines and are in line with previous data. The impact onsurvival is likely to be both due to individual surgical experience
and the collective unit expertise.
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